For the Quarter Ending June 2026
Epinephrine Prices in North America
- In the United States, Epinephrine Price Index rose in Q2 2026, driven by significant producer-level inflation.
- Epinephrine production costs increased in Q2 2026, influenced by 5.5% Producer Price Index year-over-year in June 2026.
- Demand for Epinephrine remained stable in Q2 2026, supported by a low 4.2% unemployment rate in June 2026.
- The Epinephrine Price Forecast suggests continued upward pressure from elevated energy and raw material costs in Q2 2026.
- US chemical production expanded in early 2026, despite 0.7% industrial production growth year-over-year in June 2026.
- Crude oil prices were elevated and volatile through Q2 2026, impacting energy and feedstock expenses.
- Consumer-level inflation, indicated by 3.5% Consumer Price Index year-over-year in June 2026, raised operational costs.
- Strong consumer spending, with retail sales up 6.9% year-over-year in May 2026, supported healthcare funding.
- Moderate consumer optimism, with an index of 91.2 in June 2026, supported stable healthcare access.
Why did the price of Epinephrine change in June 2026 in North America?
- Producer Price Index rose 5.5% in June 2026, increasing raw material costs.
- Consumer Price Index increased 3.5% in June 2026, raising labor costs.
- Elevated crude oil prices in Q2 2026 raised transportation and energy costs.
Epinephrine Prices in APAC
- In China, Epinephrine Price Index rose in Q2 2026, influenced by rising production costs in June 2026.
- Epinephrine production costs increased in Q2 2026, with PPI rising 4.1% in June 2026.
- Volatile coal and solvent prices exerted upward pressure on API producers in Q2 2026.
- Epinephrine demand remained stable in Q2 2026, supported by structural pharmaceutical market growth.
- China's industrial production grew 5.3% in June 2026, indicating robust Epinephrine manufacturing.
- The Manufacturing Index expanded in June 2026, supporting efficient pharmaceutical supply chains.
- Epinephrine exports from China boomed in May 2026 due to Strait of Hormuz disruptions.
- Overseas buyers held high inventories in May 2026, reducing orders for Chinese chemicals.
- Epinephrine Price Index faced downward pressure in June 2026 as Middle East supply resumed.
- Low CPI at 1.0% in June 2026 indicated weak inflationary pressure, stabilizing operational costs.
Why did the price of Epinephrine change in June 2026 in APAC?
- Producer Price Index rose 4.1% in June 2026, increasing Epinephrine manufacturing input costs.
- Disruptions in the Strait of Hormuz until mid-June 2026 supported Chinese chemical exports.
- Weak domestic demand, with retail sales growing only 1.0% in June 2026, impacted market sentiment.
Epinephrine Prices in Europe
- In Germany, the Epinephrine Price Index rose quarter-over-quarter in Q2 2026, driven by elevated production costs and strengthening demand.
- Epinephrine production costs increased in Q2 2026, as producer prices rose by 2.2% year-over-year in May 2026.
- Demand for Epinephrine strengthened in Q2 2026, supported by an aging population and moderate pharmaceutical export upturn in June 2026.
- The Epinephrine Price Forecast indicates continued upward pressure due to persistently high energy and feedstock expenses in Q2 2026.
- Overall industrial production remained stagnant at 0.0% year-over-year in May 2026, impacting Epinephrine supply efficiency.
- The Manufacturing Index showed a contracting trend in June 2026, signaling a challenging industrial environment for Epinephrine production.
- Epinephrine inventory levels increased in Q2 2026, as businesses engaged in precautionary stockpiling due to geopolitical tensions.
- Consumer Price Index rose by 2.3% year-over-year in June 2026, contributing to higher operational expenses for Epinephrine manufacturers.
Why did the price of Epinephrine change in June 2026 in Europe?
- Epinephrine production costs increased due to a 2.2% rise in producer prices in May 2026.
- Energy and feedstock expenses remained persistently high in Q2 2026, driving up manufacturing costs.
- Precautionary inventory building in Q2 2026, coupled with declining production, influenced market dynamics.
For the Quarter Ending March 2026
Epinephrine Prices in North America
- In United States, the Epinephrine Price Index rose quarter-over-quarter in Q1 2026, driven by tightened supply and manufacturing delays.
- During March 2026, consumer inflation reached 3.3% year-over-year, while producer prices rose 4.0%, elevating the Epinephrine Production Cost Trend.
- The Manufacturing Index expanded in March 2026, alongside a 0.7% year-over-year industrial production increase, supporting steady pharmaceutical output.
- Retail sales grew 4.0% year-over-year in March 2026, while unemployment held at 4.3%, sustaining a strong Epinephrine Demand Outlook.
- Consumer confidence reached a 91.8 index in March 2026, encouraging consistent prescription renewals and supporting the Epinephrine Price Index.
- Pharmaceutical demand for epinephrine strengthened in Q1 2026, driven by rising incidences of severe allergic and chronic respiratory diseases.
- Epinephrine auto-injector availability remained constrained in Q1 2026, with intermittent regional stockouts persisting across the healthcare sector.
- The Epinephrine Price Forecast indicated upward pressure throughout Q1 2026 due to persistent backorders from major producers.
Why did the price of Epinephrine change in March 2026 in North America?
- Epinephrine injection supply tightened in Q1 2026 due to ongoing manufacturing delays and persistent backorders.
- Producer prices increased 4.0% year-over-year in March 2026, pushing up pharmaceutical synthesis and assembly costs.
- Strong retail sales in March 2026 sustained high consumer purchasing power for emergency allergy medications.
Epinephrine Prices in APAC
- In China, the Epinephrine Price Index rose quarter-over-quarter in Q1 2026, driven by surging healthcare demand.
- The Epinephrine Production Cost Trend increased as factory-gate prices rose 0.5% year-over-year in March 2026.
- The Epinephrine Demand Outlook strengthened alongside a 1.0% year-over-year consumer inflation increase in March 2026.
- Industrial production grew 5.7% year-over-year in March 2026, ensuring steady upstream chemical reagent and packaging manufacturing.
- Higher unemployment at 5.4% and 1.7% retail sales growth constrained discretionary pharmacy spending in March 2026.
- A low consumer confidence index of 91.6 in February 2026 limited preventative auto-injector stocking purchases.
- The Manufacturing Index expanded in March 2026, supporting robust pharmaceutical packaging and medical device assembly.
- Epinephrine demand surged due to urbanization-driven allergies and expanded government healthcare reforms in March 2026.
- Production costs for methylamine stabilized as upstream ammonia supply remained adequate across China in February 2026.
- The Epinephrine Price Forecast stabilized as active pharmaceutical ingredient safety stocks expanded significantly in March 2026.
Why did the price of Epinephrine change in March 2026 in APAC?
- Surging urbanization-driven allergies and expanded government healthcare reforms elevated domestic Epinephrine consumption in March 2026.
- Factory-gate prices rose 0.5% year-over-year, directly increasing upstream chemical precursor procurement costs in March 2026.
- Catechol exports faced severe maritime shipping disruptions in the Strait of Hormuz during March 2026.
Epinephrine Prices in Europe
- In Germany, the Epinephrine Price Index rose quarter-over-quarter in Q1 2026, driven by surging methanol feedstock costs.
- The Epinephrine Production Cost Trend increased in March 2026 as broader energy costs surged alongside 2.7% CPI inflation.
- The Epinephrine Demand Outlook stabilized in Q1 2026 despite a 4.0% unemployment rate and -2.0% retail sales decline.
- Pharmaceutical sector methanol feedstock sales stabilized in Q1 2026, contrasting with 0.0% industrial production and -0.2% PPI deflation.
- The Manufacturing Index contracted in March 2026, aligning with deeply negative consumer confidence at -24.7, impacting broader markets.
- Methanol feedstock inventories for Epinephrine lengthened in January 2026, while overall supply remained long during the same period.
- Phenol feedstock demand weakened in February 2026, and methanol feedstock trade flows experienced disruptions in March 2026.
- The Epinephrine Price Forecast indicated upward pressure in Q1 2026 due to rising phenol feedstock costs in February.
Why did the price of Epinephrine change in March 2026 in Europe?
- Methanol feedstock costs for Epinephrine surged in March 2026, driving up overall regional production expenses.
- Broader energy costs impacting Epinephrine feedstocks surged in March 2026, adding significant upward market pressure.
- Methanol feedstock trade flows for Epinephrine experienced disruptions in March 2026, tightening regional supply availability.
For the Quarter Ending December 2025
Epinephrine Prices in North America
- In United States, the Epinephrine Price Index rose quarter-over-quarter in Q4 2025, driven by rising production costs and strengthened pharmaceutical market.
- Epinephrine production costs rose from a 2.7% CPI increase in December 2025 and a 3.0% PPI increase in November 2025.
- Natural gas prices strengthened in late Q4 2025, contributing to higher energy expenses for Epinephrine production.
- Epinephrine demand was supported by strengthened pharmaceutical market performance in Q4 2025 and steady novel drug introductions in October 2025.
- US biopharmaceutical manufacturing investment remained robust in Q4 2025, supporting supply chain stability.
- Chlorine feedstock costs weakened in November 2025, offering some relief to Epinephrine production expenses.
- A 4.4% unemployment rate in December 2025 and 3.3% retail sales growth in November 2025 supported demand.
- Industrial production increased 2.0% in December 2025; consumer confidence at 89.1 supported a stronger economy.
Why did the price of Epinephrine change in December 2025 in North America?
- Rising input costs, with CPI up 2.7% in December 2025, elevated Epinephrine raw material and labor.
- Producer costs for Epinephrine climbed, PPI up 3.0% in November 2025, reflecting higher manufacturing inputs.
- Strengthened pharmaceutical market performance in Q4 2025 and robust biopharmaceutical investment supported Epinephrine demand.
Epinephrine Prices in APAC
- In China, the Epinephrine Price Index remained stable quarter-over-quarter in Q4 2025, influenced by mixed macroeconomic signals.
- Epinephrine production costs declined in December 2025, as the Producer Price Index fell by 1.9% year-on-year.
- Demand for Epinephrine faced headwinds in December 2025, with retail sales growth weakening to 0.9% year-on-year.
- The Manufacturing Index expanded in December 2025, indicating robust industrial activity and stable supply chains.
- Industrial production advanced by 5.2% year-on-year in December 2025, supporting overall economic health and pharmaceutical distribution.
- Input cost inflation for manufacturing accelerated in December 2025, driven by higher raw material prices and crude oil support.
- Chinese companies increased injectable drug exports in 2025, responding to strong demand in high-regulation markets.
- The Consumer Price Index rose by 0.8% year-on-year in December 2025, reflecting subdued inflationary pressures.
Why did the price of Epinephrine change in December 2025 in APAC?
- Producer Price Index declined by 1.9% year-on-year in December 2025, reducing Epinephrine production costs.
- Weakened retail sales growth of 0.9% year-on-year in December 2025 indicated subdued consumer demand.
- Input cost inflation accelerated in December 2025, driven by higher raw material prices and crude oil support.
Epinephrine Prices in Europe
- In Germany, the Epinephrine Price Index fell in Q4 2025, primarily due to decreasing producer input costs.
- Epinephrine production costs declined in December 2025 as the Producer Price Index decreased 2.5% year-over-year.
- Overall consumer inflation, measured by CPI, was 1.8% year-over-year in December 2025, influencing operational expenses.
- The Manufacturing Index contracted in December 2025, indicating a slowdown in broader industrial activity.
- Industrial production showed modest 0.8% year-over-year growth in October 2025, supporting manufacturing stability.
- Epinephrine demand outlook faced headwinds from 6.2% unemployment in December 2025, impacting healthcare budgets.
- Consumer confidence remained pessimistic at -17.5 in December 2025, reflecting broader economic anxieties.
- Vulnerabilities in pharmaceutical supply chains were ongoing in late 2025, affecting Epinephrine availability.
- Germany's gas storage facilities met targets by October and November 2025, stabilizing energy feedstock costs.
- Healthcare sector M&A activity remained highly active in Q4 2025, with transaction momentum accelerating.
Why did the price of Epinephrine change in December 2025 in Europe?
- Epinephrine production costs declined in December 2025, as PPI fell 2.5% year-over-year.
- The Manufacturing Index contracted in December 2025, indicating a broader industrial slowdown.
- Pharmaceutical supply chain vulnerabilities persisted in late 2025, impacting Epinephrine availability.
For the Quarter Ending September 2025
Epinephrine Prices in North America
- In United States, the Epinephrine Price Index rose quarter-over-quarter in Q3 2025, driven by increasing producer-level costs.
- Epinephrine production costs increased due to a 3.0% CPI rise in September 2025, impacting overall operational expenses.
- Producer-level costs for Epinephrine manufacturing rose by 2.6% year-over-year in August 2025, affecting raw material prices.
- Demand for Epinephrine remained robust in 2025, supported by accelerating national health expenditures in the healthcare sector.
- Prescription drug spending showed a sustained increase in 2025, bolstering the Epinephrine demand outlook.
- US industrial production saw a marginal 0.1% year-over-year increase in September 2025, indicating slow sector growth.
- The broader US chemical industry experienced persistent overcapacity in Q3 2025, influencing general supply dynamics.
- Natural gas prices, a key energy feedstock for chemical production, settled lower in September 2025.
- An inventory glut in the chemical industry during Q3 2025 contributed to broader oversupply conditions.
Why did the price of Epinephrine change in September 2025 in North America?
- Rising producer costs, evidenced by a 2.6% PPI increase in August 2025, pressured Epinephrine manufacturing expenses.
- Increased consumer-level inflation, with CPI up 3.0% in September 2025, elevated Epinephrine operational costs.
- Sustained demand for prescription drugs in 2025 supported Epinephrine market stability despite broader chemical overcapacity.
Epinephrine Prices in APAC
- In China, the Epinephrine Price Index fell quarter-over-quarter in Q3 2025, influenced by declining production costs and deflationary pressures.
- Epinephrine production costs declined in Q3 2025, as the Producer Price Index fell by 2.3% in September 2025.
- Methylamine feedstock costs, a key input, decreased in China during Q3 2025 due to persistent oversupply.
- Demand for Epinephrine remained stable in Q3 2025, supported by robust industrial production growth of 6.5% in September 2025.
- Stable retail sales, increasing by 3.0% in September 2025, indirectly supported healthcare funding and access to medicines.
- Deflationary pressures, with CPI falling by 0.3% in September 2025, exerted downward influence on pharmaceutical pricing.
- Elevated methylamine inventories accumulated in China during Q3 2025, reflecting broader chemical industry oversupply.
- The Manufacturing Index contracted in September 2025, signaling broader economic weakness impacting the sector.
Why did the price of Epinephrine change in September 2025 in APAC?
- Declining Producer Price Index by 2.3% in September 2025 reduced manufacturing input costs.
- Methylamine feedstock costs decreased in Q3 2025 due to oversupply, lowering production expenses.
- Deflationary Consumer Price Index of -0.3% in September 2025 created downward pressure on pharmaceutical prices.
Epinephrine Prices in Europe
- In Germany, the Epinephrine Price Index remained stable quarter-over-quarter in Q3 2025, reflecting balanced market pressures.
- Production costs faced downward pressure from a 1.7% year-over-year PPI decline in September 2025.
- However, broader inflationary pressures, with CPI rising 2.4% year-over-year in September 2025, impacted input costs.
- Demand outlook was tempered by Germany's industrial production declining 1.0% year-over-year in September 2025.
- Despite a contracting Manufacturing Index in September 2025, pharmaceutical sector output firmed, showing resilience.
- Elevated electricity prices for businesses in Q3 2025 continued to pressure Epinephrine production expenses.
- Chemical industry inventories shrank in Q3 2025 due to accelerating destocking, influencing supply dynamics.
- A low unemployment rate of 3.9% in September 2025 supported consumer affordability for essential healthcare.
- The Epinephrine price forecast suggests continued stability, balancing cost pressures against weak overall demand.
Why did the price of Epinephrine change in September 2025 in Europe?
- Deflationary producer prices, down 1.7% year-over-year in September 2025, reduced Epinephrine production costs.
- Elevated electricity prices for businesses in Q3 2025 pressured overall Epinephrine production expenses.
- Weakened chemical demand and declining industrial production in Q3 2025 limited Epinephrine price increases.
